MPDL3280A Treatment in Patients With Locally Advance or Metastatic Non-small Cell Lung, Bladder and Triple Negative Breast Cancer After Investigational Imaging
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 22 Dec 2016
At a glance
- Drugs Atezolizumab (Primary)
- Indications Advanced breast cancer; Bladder cancer; Non-small cell lung cancer; Solid tumours
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 19 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 29 Mar 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.